mylan-will-develop-and-market-insulin-generics-including-biocon-s-glargine-lispro-and-aspart

Mylan to develop, market Biocon generic insulin

  • India
  • |
  • News
  • |
  • By Narayanan Suresh
  • |
  • 0 Comment

Bangalore: India's No 2 biotech company, Bangalore-based Biocon has announced a strategic partnership with global generics major, Mylan, based in Pittsburgh, US,... Read more

padma-shri-prof-krishnaswamy-vijayraghavan-eminent-geneticist-and-director-national-center-for-biological-sciences-ncbs-is-now-the-secretary-of-the-department-of-biotechnology-dbt-india

India DBT secretary: We can reach $100 bn by 2025

  • India
  • |
  • Influencers
  • |
  • By Narayanan Suresh
  • |
  • 0 Comment

The Government of India boasts of seven major scientific departments, covering various domains of science ranging from biotechnology to space research. Among these,... Read more

drug-controller-general-of-india-dgci-all-generic-drug-makers-need-to-conduct-trials-and-seek-approval-within-18-months

Indian regulator cracks down on banned drugs

  • India
  • |
  • News
  • |
  • By Narayanan Suresh
  • |
  • 0 Comment

Bangalore: As a first step to prevent misuse of drugs, which have been banned abroad from being sold freely in the country, Drug Controller General of India (DGCI)... Read more

india-s-national-centre-for-disease-informatics-and-research-ncdir-will-be-the-hub-for-setting-up-of-the-national-registry-for-stroke

India starts national registry for stroke patients

  • India
  • |
  • News
  • |
  • By Narayanan Suresh
  • |
  • 0 Comment

Bangalore: After the successful compilation of India's National Cancer Registry, the first of its kind for any disease in the country over the last two decades,... Read more

mr-marc-casper-president-and-ceo-thermo-fisher-scientific-us

Thermo Fisher to grow APAC revenue share to 25%

  • US
  • |
  • Influencers
  • |
  • By Narayanan Suresh
  • |
  • 0 Comment

Thermo Fisher Scientific, a global player in serving science, has revenues of $12 billion and boasts of approximately 39,000 employees worldwide. It serves customers... Read more

able-dbt-report-indian-biotechnology-the-roadmap-to-the-next-decade-and-beyond

India biotech to be $125 billion gorilla by 2025

  • India
  • |
  • Analysis
  • |
  • By Narayanan Suresh
  • |
  • 0 Comment

Bangalore: "A dynamic and vibrant biotechnology industry would be one of the main engines of innovation in India and will establish the country as a global destination... Read more

curtain-raiser-bangalore-india-bio-2013

Bangalore India Bio 2013 promises a new look

Bangalore: The Department of Information Technology, Biotechnology and Science and Technology, Government of Karnataka, Vision Group on Biotechnology and MM Activ... Read more

Biotech leaders optimistic about future

Biotech leaders optimistic about future: BIO survey

  • US
  • |
  • News
  • |
  • By Narayanan Suresh
  • |
  • 0 Comment

Boston: Despite a slowing global economy, regulatory delays and policy paralysis in many nations, world's biotechnology leaders are still optimistic about the future... Read more

Singapore is third most innovative country in biotech

Singapore is world’s third most innovative country in...

  • Singapore
  • |
  • News
  • |
  • By Narayanan Suresh
  • |
  • 5 Comments

Boston: Singapore has emerged as the world's 3rd most biotech innovative country in the annual ranking of countries according to their score for innovation in biotech,... Read more

India announces new biosimilar regulatory guidelines

India announces new biosimilar regulatory guidelines

  • India
  • |
  • Regulatory
  • |
  • By Narayanan Suresh
  • |
  • 0 Comment

Boston: India has announced the much-awaited new and simple regulatory guidelines for similar biologics which have been approved and marketed in USA or Europe for... Read more

Special Features

Survey Box

Ranbaxy Controversy

Will the Ranbaxy controversy end the Indian pharma dominion in the US market?

Send this article by email

X